The BMNR stock price forecast benefits from stable macro conditions for biotech funding and regulatory approvals, supporting longer-term bullish scenarios. To curate the list of the 10 best falling stocks to buy according to hedge funds, we used the Finviz stock screener and Yahoo Finance. We defined falling stocks as those trading within 0% to 3% of their 52-week lows. Using the Finviz stock screener, we got an aggregated list of stocks that fit our criteria. Next, we ranked these stocks based on the number of hedge funds holding each stock during Q2 2024, as per Insider Monkey’s database. All indicators were recorded on October 21st, 2024. Please note that the list is ranked in ascending order of the number of hedge funds. Despite this, its stock market valuation stands at a mere fraction of that figure, hovering around $215 million. This vast chasm between the company's tangible assets and its share price presents a compelling puzzle, prompting a closer look at the factors driving this deep discount and the potential catalysts for future value realization. Strong sector demand and favorable sentiment boost BMNR’s forecast; data models project steady volume growth alongside price appreciation.